Cel Sci Corporation (CVM)

[Biobonic]

Seems that the Underwriters missed out when they didn't exercise their greenshoe/over-allotment option.

On December 11, 2020, the Company sold 1,000,000 shares of common stock at a public offering price of $ 14.65 per share and received aggregate proceeds of approximately $ 13.6 million. Under the terms of the Underwriting Agreement the Company granted the Underwriters a 30-day option to purchase up to an additional 150,000 shares of common stock at the public offering price to cover over-allotments.


Price started moving end Jan25, 2021.



Scan the biotechs that are in late stage as Cel Sci is - see a significant number of biotechs that tap the market for $50 - $200 million, to be on the safe side, have a reserve in case the binary event goes against them.


Geert asks for $15 million, a measly $15 mil - money that is essentially committed to the manu facility upgrade.


When one gives that some thought:

He could have raised $50 -$75 million for financial backup. If Multikine fails, that raised money would have allowed him to fiddle with LEAPS until retirement.

No, he didn't...just $15 mil because it's already committed...


That is one ballsy move.